Cargando…

Focus on the role of mitochondria in NLRP3 inflammasome activation: A prospective target for the treatment of ischemic stroke (Review)

Post-ischemic neuroinflammation induced by the innate local immune response is a major pathophysiological feature of cerebral ischemic stroke, which remains the leading cause of mortality and disability worldwide. NLR family pyrin domain containing (NLRP)3 inflammasome crucially mediates post-ischem...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Xiaolu, Zeng, Wenyun, Zhang, Yue, Yu, Qun, Zeng, Miao, Gan, Jiali, Zhang, Wenlan, Jiang, Xijuan, Li, Huhu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2022
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9015651/ https://www.ncbi.nlm.nih.gov/pubmed/35419616 http://dx.doi.org/10.3892/ijmm.2022.5130

Ejemplares similares

Interactions between NLRP3 inflammasome and glycolysis in macrophages: New insights into chronic inflammation pathogenesis
por: Yu, Qun, et al.
Publicado: (2021)

Inhibitors of the NLRP3 inflammasome pathway as promising therapeutic candidates for inflammatory diseases (Review)
por: Zhang, Xiaolu, et al.
Publicado: (2023)

Jia-Wei-Kai-Xin-San Treatment Alleviated Mild Cognitive Impairment through Anti-Inflammatory and Antiapoptotic Mechanisms in SAMP8 Mice
por: Zhang, Xiaolu, et al.
Publicado: (2023)

Anti-inflammatory therapy of atherosclerosis: focusing on IKKβ
por: Gan, Jiali, et al.
Publicado: (2023)

Does an apple a day keep away diseases? Evidence and mechanism of action
por: Zhang, Yue, et al.
Publicado: (2023)

Inhibition of NLRP3 Inflammasome: A Prospective Target for the Treatment of Ischemic Stroke
por: Feng, Ya-Shuo, et al.
Publicado: (2020)

Pharmacological intervention of curcumin via the NLRP3 inflammasome in ischemic stroke
por: Du, Xiaoxue, et al.
Publicado: (2023)

Effect of PCSK9 Inhibitor on Blood Lipid Levels in Patients with High and Very-High CVD Risk: A Systematic Review and Meta-Analysis
por: Zhang, Yue, et al.
Publicado: (2022)

The selective NLRP3 inhibitor MCC950 hinders atherosclerosis development by attenuating inflammation and pyroptosis in macrophages
por: Zeng, Wenyun, et al.
Publicado: (2021)

NLRP3 inflammasome as a potential treatment in ischemic stroke concomitant with diabetes
por: Hong, Pu, et al.
Publicado: (2019)

Vinpocetine Attenuates Ischemic Stroke Through Inhibiting NLRP3 Inflammasome Expression in Mice
por: Han, Dong, et al.
Publicado: (2020)

Mitochondria and the NLRP3 Inflammasome in Alcoholic and Nonalcoholic Steatohepatitis
por: Torres, Sandra, et al.
Publicado: (2022)

Intravenous immunoglobulin suppresses NLRP1 and NLRP3 inflammasome-mediated neuronal death in ischemic stroke
por: Yang-Wei Fann, D, et al.
Publicado: (2013)

Inhibitors of NLRP3 Inflammasome in Ischemic Heart Disease: Focus on Functional and Redox Aspects
por: Pagliaro, Pasquale, et al.
Publicado: (2023)

NLRP3 inflammasome as a novel therapeutic target for heart failure
por: Wang, Shuangcui, et al.
Publicado: (2021)

Focus on the Role of NLRP3 Inflammasome in Diseases
por: Fusco, Roberta, et al.
Publicado: (2020)

NLRP3 inflammasome-mediated pyroptosis contributes to the pathogenesis of non-ischemic dilated cardiomyopathy
por: Zeng, Cheng, et al.
Publicado: (2020)

Trends in NLRP3 inflammasome research in ischemic stroke from 2011 to 2022: A bibliometric analysis
por: Zhu, Hua, et al.
Publicado: (2023)

Pyroptosis in NLRP3 inflammasome-related atherosclerosis
por: Zeng, Xiang, et al.
Publicado: (2022)

Relevant mediators involved in and therapies targeting the inflammatory response induced by activation of the NLRP3 inflammasome in ischemic stroke
por: Xu, Qingxue, et al.
Publicado: (2021)

The role of NLRP3 inflammasome-mediated pyroptosis in ischemic stroke and the intervention of traditional Chinese medicine
por: Long, Jia-Xin, et al.
Publicado: (2023)

The role of NLRP3 inflammasome in stroke and central poststroke pain
por: Li, Shao-jun, et al.
Publicado: (2018)

NLRP3 Inflammasome and Inflammatory Diseases
por: Wang, Zheng, et al.
Publicado: (2020)

Sacubitril/valsartan: research progress of multi-channel therapy for cardiorenal syndrome
por: Wang, Shuangcui, et al.
Publicado: (2023)

Hypoxia-inducible factor-1 α and RIP3 triggers NLRP3 inflammasome in ischemic stroke
por: Jiang, Qian, et al.
Publicado: (2018)

Magnetic Resonance Images, Pathological Features of Thrombus, and Expression of NLRP Inflammasome in Patients with Acute Ischemic Stroke
por: Wang, Xiaoqin, et al.
Publicado: (2022)

High glucose enhances the activation of NLRP3 inflammasome by ambient fine particulate matter in alveolar macrophages
por: Mo, Yiqun, et al.
Publicado: (2023)

Oxidative-Damaged Mitochondria Activate GABARAPL1-Induced NLRP3 Inflammasomes in an Autophagic-Exosome Manner after Acute Myocardial Ischemia
por: Zhang, Tiechun, et al.
Publicado: (2022)

Effects and mechanisms of SGLT2 inhibitors on the NLRP3 inflammasome, with a focus on atherosclerosis
por: Yang, Liu, et al.
Publicado: (2022)

Therapeutic Candidates for Alzheimer’s Disease: Saponins
por: Zhang, Ruifeng, et al.
Publicado: (2023)

The role of mitochondria-associated membranes mediated ROS on NLRP3 inflammasome in cardiovascular diseases
por: Zhao, Jiahao, et al.
Publicado: (2022)

Matrix Metalloproteinase 9 Secreted by Hypoxia Cardiac Fibroblasts Triggers Cardiac Stem Cell Migration In Vitro
por: Gao, Qing, et al.
Publicado: (2015)

Research Progress of Mitochondrial Mechanism in NLRP3 Inflammasome Activation and Exercise Regulation of NLRP3 Inflammasome
por: Zhang, Tan, et al.
Publicado: (2021)

Ischemic Preconditioning Provides Neuroprotection by Inhibiting NLRP3 Inflammasome Activation and Cell Pyroptosis
por: Gao, Li, et al.
Publicado: (2023)

NLRP3 Inflammasome in the Pathophysiology of Hemorrhagic Stroke: A Review
por: Luo, Yujie, et al.
Publicado: (2019)

Role of NLRP3 inflammasome in diabetes and COVID-19 role of NLRP3 inflammasome in the pathogenesis and treatment of COVID-19 and diabetes NLRP3 inflammasome in diabetes and COVID-19 intervention
por: Zhang, Jiayu, et al.
Publicado: (2023)

The NLRP6 inflammasome
por: Zheng, Danping, et al.
Publicado: (2020)

Mitochondria Fusion upon SERCA Inhibition Prevents Activation of the NLRP3 Inflammasome in Human Monocytes
por: Pereira, Ana Catarina, et al.
Publicado: (2022)

Oleanolic Acid Provides Neuroprotection against Ischemic Stroke through the Inhibition of Microglial Activation and NLRP3 Inflammasome Activation
por: Sapkota, Arjun, et al.
Publicado: (2022)

Celastrol ameliorates inflammation through inhibition of NLRP3 inflammasome activation
por: Yu, Xianjun, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_n3j9hpera7mnvtqiujt87ofpbj